Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rapid Micro Biosystems commercializes the Growth Direct System, a fully automated, non-destructive growth-based platform for rapid microbial contamination detection in pharmaceutical and biotech manufacturing. The system is used globally by manufacturers to accelerate quality control testing such as environmental monitoring, water testing, bioburden testing, and sterility assurance. The technology enables faster product release and improved compliance with regulatory standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rapid Micro Biosystems.